US Stock MarketDetailed Quotes

BioXcel Therapeutics (BTAI)

Watchlist

1.060
-0.040-3.64%

Close Apr 24 15:59 ET

1.090
+0.030+2.83%

Post 20:01 ET

28.70MMarket Cap-0.18P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioXcel Therapeutics (BTAI) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

-71.67%642K

-30.05%256K

-54.21%98K

-89.13%120K

-71.13%168K

64.20%2.27M

-2.66%366K

-37.24%214K

141.58%1.1M

182.52%582K

Operating revenue

-71.67%642K

-30.05%256K

-54.21%98K

-89.13%120K

-71.13%168K

64.20%2.27M

-2.66%366K

-37.24%214K

141.58%1.1M

182.52%582K

Cost of revenue

-92.35%164K

-96.15%32K

-99.06%11K

72.58%107K

-82.50%14K

70.08%2.14M

16.53%832K

128.52%1.17M

138.46%62K

788.89%80K

Gross profit

288.62%478K

148.07%224K

109.10%87K

-98.75%13K

-69.32%154K

2.50%123K

-37.87%-466K

-459.06%-956K

141.76%1.04M

154.82%502K

Operating expense

-21.84%50.75M

5.11%10.51M

10.46%14.12M

-9.25%15.87M

-58.43%10.25M

-61.29%64.93M

-48.84%10M

-70.92%12.78M

-66.92%17.48M

-52.01%24.67M

Selling and administrative expenses

-40.58%20.49M

-7.06%3.81M

-29.96%5.38M

-40.65%5.61M

-57.03%5.7M

-58.65%34.49M

-57.37%4.09M

-68.44%7.68M

-63.47%9.45M

-43.78%13.26M

-Selling and marketing expense

-70.70%407K

-82.37%85K

-58.78%115K

105.29%38K

----

-88.87%1.39M

51.10%482K

-90.67%279K

-114.94%-718K

----

-General and administrative expense

-39.32%20.09M

2.99%3.72M

-28.88%5.27M

-45.21%5.57M

-57.03%5.7M

-53.33%33.1M

-61.09%3.61M

-65.33%7.4M

-51.73%10.17M

-43.78%13.26M

Research and development costs

-0.60%30.25M

13.56%6.7M

71.34%8.74M

27.69%10.26M

-60.06%4.55M

-63.91%30.44M

-40.60%5.9M

-74.00%5.1M

-70.22%8.03M

-58.99%11.4M

Operating profit

22.43%-50.27M

1.71%-10.28M

-2.14%-14.03M

3.58%-15.85M

58.20%-10.1M

61.34%-64.8M

47.37%-10.46M

68.87%-13.74M

68.63%-16.44M

52.80%-24.16M

Net non-operating interest income expense

-27.07%-15.92M

-11.22%-4.08M

-30.34%-4.14M

-31.79%-3.99M

-39.62%-3.71M

-63.43%-12.53M

-47.21%-3.66M

-45.33%-3.17M

-84.92%-3.03M

-96.75%-2.66M

Non-operating interest income

-59.03%1.07M

-12.77%321K

-61.69%236K

-65.72%230K

-70.54%279K

-53.94%2.6M

-61.10%368K

-42.32%616K

-58.61%671K

-53.00%947K

Non-operating interest expense

12.26%16.98M

9.03%4.4M

15.38%4.37M

14.11%4.22M

10.70%3.99M

13.63%15.13M

17.38%4.03M

16.54%3.79M

13.53%3.7M

7.13%3.61M

Other net income (expense)

-120.93%-3.71M

-44.52%1.81M

-490.32%-12.74M

-94.12%657K

20,396.88%6.56M

570.47%17.73M

2,924.07%3.27M

178.31%3.26M

1,980.07%11.17M

113.01%32K

Special income (charges)

92.05%-194K

--0

87.51%-194K

--0

----

41.36%-2.44M

---32K

62.70%-1.55M

---856K

----

-Less：Restructuring and merger&acquisition

-92.05%194K

--0

-87.51%194K

--0

----

-41.36%2.44M

--32K

-62.70%1.55M

--856K

----

Other non- operating income (expenses)

-117.44%-3.52M

-45.06%1.81M

-360.45%-12.55M

-94.54%657K

20,396.88%6.56M

5,020.05%20.17M

2,953.70%3.3M

96,440.00%4.82M

2,139.48%12.03M

113.01%32K

Income before tax

-17.28%-69.9M

-15.53%-12.55M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

66.71%-59.6M

51.21%-10.86M

72.96%-13.65M

84.49%-8.3M

49.26%-26.79M

Income tax

Net income

-17.28%-69.9M

-15.53%-12.55M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

66.71%-59.6M

51.21%-10.86M

72.96%-13.65M

84.49%-8.3M

49.26%-26.79M

Net income continuous Operations

-17.28%-69.9M

-15.53%-12.55M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

66.71%-59.6M

51.21%-10.86M

72.96%-13.65M

84.49%-8.3M

49.26%-26.79M

Minority interest income

Net income attributable to the parent company

-17.28%-69.9M

-15.53%-12.55M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

66.71%-59.6M

51.21%-10.86M

72.96%-13.65M

84.49%-8.3M

49.26%-26.79M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-17.28%-69.9M

-15.53%-12.55M

-126.45%-30.91M

-131.20%-19.19M

72.92%-7.25M

66.71%-59.6M

51.21%-10.86M

72.96%-13.65M

84.49%-8.3M

49.26%-26.79M

Basic earnings per share

75.63%-5.73

84.26%-0.5619

57.67%-2.18

25.76%-2.45

89.20%-1.5

76.09%-23.51

70.64%-3.57

81.29%-5.15

88.73%-3.3

52.82%-13.89

Diluted earnings per share

75.63%-5.73

84.26%-0.5619

57.67%-2.18

25.76%-2.45

89.20%-1.5

76.09%-23.51

70.64%-3.57

81.29%-5.15

88.73%-3.3

52.82%-13.89

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	-71.67%642K	-30.05%256K	-54.21%98K	-89.13%120K	-71.13%168K	64.20%2.27M	-2.66%366K	-37.24%214K	141.58%1.1M	182.52%582K
Operating revenue	-71.67%642K	-30.05%256K	-54.21%98K	-89.13%120K	-71.13%168K	64.20%2.27M	-2.66%366K	-37.24%214K	141.58%1.1M	182.52%582K
Cost of revenue	-92.35%164K	-96.15%32K	-99.06%11K	72.58%107K	-82.50%14K	70.08%2.14M	16.53%832K	128.52%1.17M	138.46%62K	788.89%80K
Gross profit	288.62%478K	148.07%224K	109.10%87K	-98.75%13K	-69.32%154K	2.50%123K	-37.87%-466K	-459.06%-956K	141.76%1.04M	154.82%502K
Operating expense	-21.84%50.75M	5.11%10.51M	10.46%14.12M	-9.25%15.87M	-58.43%10.25M	-61.29%64.93M	-48.84%10M	-70.92%12.78M	-66.92%17.48M	-52.01%24.67M
Selling and administrative expenses	-40.58%20.49M	-7.06%3.81M	-29.96%5.38M	-40.65%5.61M	-57.03%5.7M	-58.65%34.49M	-57.37%4.09M	-68.44%7.68M	-63.47%9.45M	-43.78%13.26M
-Selling and marketing expense	-70.70%407K	-82.37%85K	-58.78%115K	105.29%38K	----	-88.87%1.39M	51.10%482K	-90.67%279K	-114.94%-718K	----
-General and administrative expense	-39.32%20.09M	2.99%3.72M	-28.88%5.27M	-45.21%5.57M	-57.03%5.7M	-53.33%33.1M	-61.09%3.61M	-65.33%7.4M	-51.73%10.17M	-43.78%13.26M
Research and development costs	-0.60%30.25M	13.56%6.7M	71.34%8.74M	27.69%10.26M	-60.06%4.55M	-63.91%30.44M	-40.60%5.9M	-74.00%5.1M	-70.22%8.03M	-58.99%11.4M
Operating profit	22.43%-50.27M	1.71%-10.28M	-2.14%-14.03M	3.58%-15.85M	58.20%-10.1M	61.34%-64.8M	47.37%-10.46M	68.87%-13.74M	68.63%-16.44M	52.80%-24.16M
Net non-operating interest income expense	-27.07%-15.92M	-11.22%-4.08M	-30.34%-4.14M	-31.79%-3.99M	-39.62%-3.71M	-63.43%-12.53M	-47.21%-3.66M	-45.33%-3.17M	-84.92%-3.03M	-96.75%-2.66M
Non-operating interest income	-59.03%1.07M	-12.77%321K	-61.69%236K	-65.72%230K	-70.54%279K	-53.94%2.6M	-61.10%368K	-42.32%616K	-58.61%671K	-53.00%947K
Non-operating interest expense	12.26%16.98M	9.03%4.4M	15.38%4.37M	14.11%4.22M	10.70%3.99M	13.63%15.13M	17.38%4.03M	16.54%3.79M	13.53%3.7M	7.13%3.61M
Other net income (expense)	-120.93%-3.71M	-44.52%1.81M	-490.32%-12.74M	-94.12%657K	20,396.88%6.56M	570.47%17.73M	2,924.07%3.27M	178.31%3.26M	1,980.07%11.17M	113.01%32K
Special income (charges)	92.05%-194K	--0	87.51%-194K	--0	----	41.36%-2.44M	---32K	62.70%-1.55M	---856K	----
-Less：Restructuring and merger&acquisition	-92.05%194K	--0	-87.51%194K	--0	----	-41.36%2.44M	--32K	-62.70%1.55M	--856K	----
Other non- operating income (expenses)	-117.44%-3.52M	-45.06%1.81M	-360.45%-12.55M	-94.54%657K	20,396.88%6.56M	5,020.05%20.17M	2,953.70%3.3M	96,440.00%4.82M	2,139.48%12.03M	113.01%32K
Income before tax	-17.28%-69.9M	-15.53%-12.55M	-126.45%-30.91M	-131.20%-19.19M	72.92%-7.25M	66.71%-59.6M	51.21%-10.86M	72.96%-13.65M	84.49%-8.3M	49.26%-26.79M
Income tax
Net income	-17.28%-69.9M	-15.53%-12.55M	-126.45%-30.91M	-131.20%-19.19M	72.92%-7.25M	66.71%-59.6M	51.21%-10.86M	72.96%-13.65M	84.49%-8.3M	49.26%-26.79M
Net income continuous Operations	-17.28%-69.9M	-15.53%-12.55M	-126.45%-30.91M	-131.20%-19.19M	72.92%-7.25M	66.71%-59.6M	51.21%-10.86M	72.96%-13.65M	84.49%-8.3M	49.26%-26.79M
Minority interest income
Net income attributable to the parent company	-17.28%-69.9M	-15.53%-12.55M	-126.45%-30.91M	-131.20%-19.19M	72.92%-7.25M	66.71%-59.6M	51.21%-10.86M	72.96%-13.65M	84.49%-8.3M	49.26%-26.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-17.28%-69.9M	-15.53%-12.55M	-126.45%-30.91M	-131.20%-19.19M	72.92%-7.25M	66.71%-59.6M	51.21%-10.86M	72.96%-13.65M	84.49%-8.3M	49.26%-26.79M
Basic earnings per share	75.63%-5.73	84.26%-0.5619	57.67%-2.18	25.76%-2.45	89.20%-1.5	76.09%-23.51	70.64%-3.57	81.29%-5.15	88.73%-3.3	52.82%-13.89
Diluted earnings per share	75.63%-5.73	84.26%-0.5619	57.67%-2.18	25.76%-2.45	89.20%-1.5	76.09%-23.51	70.64%-3.57	81.29%-5.15	88.73%-3.3	52.82%-13.89
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

No. Symbol 5D % Chg

United Microelectronics

Middle East conflict spreads to the stock market! How should investors respond?

According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm